2017 CPhI North America – Exhibitor Showcase Sponsors

CPhI North America assembled leading pharmaceutical professionals to provide a forum for solving some of the pharmaceutical industry’s most pressing challenges.

One of the highlights of the CPhI North America conference was LGM Pharma’s presentation at the Exhibitor Showcase. The presenter was LGM Pharma’s Commercial Director, Gideon Schurder. He gave an in-depth look at the calamitous effects of recent FDA warning letters and import bans and how this affects the pharmaceutical industry, API manufacturers and formulation companies.

Attendee roles covered the complete supply chain. Pharmaceutical executives along with R&D, compliance, regulatory, manufacturing, supply chain, packaging, and procurement professionals gathered to build connections, to capitalize on emerging trends, further innovation, and tackle industry challenges.

Some of the top countries in attendance were the U.S., China, India, Canada, UK, South Korea, Japan, Germany, France and Spain.

The Exhibitor Showcase titled, “The Unfortunate Aftermath of the US-FDA Slamming API Factories.” brought forth prime examples of how API factories should have acted to avoid getting themselves into trouble. Mr. Schurder also illustrated how all of this affects patients and what the Trump administration could do in order to mitigate the outcome.

“We were pleased with the accomplishments of LGM Pharma at the CPhI North America conference,” stated Steve Beagle, LGM’s Senior Vice President of Business Development. “We brought our client centric business development model to our clients’ projects showcasing our exceptional sourcing capabilities and manufacturer relationships.”


View the “The Unfortunate Aftermath of the US-FDA Slamming API Factories” video/slide presentation below:

Steve Beagle Appointed New Senior Vice President of Business Development

Steve BeagleNASHVILLE, Tennessee — LGM Pharma recently announced that Mr. Steve Beagle would be joining the organization as the Senior Vice President of Business Development.

In that capacity, Mr. Beagle will be heading up all marketing and sales activities for the company and will be working out of LGM’s new business development offices, based in New York City.

Immediately prior to joining LGM, Mr. Beagle served as North America Director of MSN Pharmaceuticals, Inc. Prior to MSN, he was North America Territory Director for Dr. Reddy’s CPS custom chemistry business. Mr. Beagle has extensive professional experience in the pharmaceutical industry and has also held key roles at DSM, BASF, Rohner AG, American Cyanamid and Hovione. He holds a BSc. from the University of Connecticut and studied at the Arnold and Marie Schwartz NY College of Pharmacy.

Speaking about his future vision for LGM, Mr. Beagle stated, “Even as a relatively young company, the key management team of LGM Pharma has already built a sophisticated global sourcing, supply chain, and sales and marketing platform with epicenters in Israel, India, China and the US. The hyper-competitive and ever-involving API landscape demands cost effective solutions. With their unique expertise in complex supply chain, API sourcing, and management, LGM Pharma is well positioned to service clients looking to outsource R&D and commercial activities. I am pleased to be joining the LGM team with the goal of building upon LGM’s existing strategic relationships while also targeting new opportunities throughout North America.”

LGM Pharma’s CPhI Comedy Night

CPHI Comedy Night Header2

LGM Pharma hosted an exclusive CPhI Comedy Night in the Good Good Comedy Theatre in Downtown Philly. CPhI is the world’s leading pharmaceutical platform that brings together pharma ingredients manufacturers, suppliers and buyers. The conference agenda tackled the most timely and business critical issues facing the pharmaceutical industry today.